NORDION
Nordion, a business unit of Sterigenics International LLC, is pleased to announce it has signed a multi-year agreement up to an additional 14-years with long-time partner Bruce Power, operator of the largest nuclear facility in the world, to provide a long-term supply of Cobalt-60 that will support health care around the world. Cobalt-60 makes an invaluable contribution to the health care industry, and is used to sterilize approximately 40 per cent of all single-use medical devices and equipment produced globally.
“In today’s world, where spread of disease is discussed daily, we are reminded how critical it is to have sterile medical products to mitigate risk to patients and the health care community,” said Scott McIntosh, President, Gamma Technologies and Corporate Services, Nordion. “This agreement signifies the value and importance that Bruce Power and Nordion place on ensuring the long-term, stable supply of Cobalt-60 for the sterilization industry and our customers.”
The World Health Organization (WHO) estimates more than 640,000 major surgeries are performed each day around the world. Sterilized disposable medical products are used in virtually all of these procedures. Cobalt-60 is supplied to the over 200 gamma irradiators in 55 countries that sterilize surgical gloves, gowns, masks, syringes, sutures, catheters, pharmaceuticals, implants and tissue, as well as several products used in the food and consumer products industries (Source: International Atomic Energy Agency).
“Bruce Power is committed to not only playing a role in providing a reliable source of affordable, clean electricity over the long-term, but securing the world’s largest source of Cobalt-60 from our Bruce B units,” said Duncan Hawthorne, President & CEO, Bruce Power. “While we are signing a long-term agreement today, our commitment is to ensure we continue to supply Cobalt-60 to Nordion as we extend the lives of our units for decades to come so they can support both the needs of a modern health care system, while providing Ontario families and businesses affordable electricity.”
If Ontario’s Long Term Energy Plan (LTEP) was fully implemented, including the life extension and refurbishment of the Bruce B units, these units would operate until approximately 2060. By moving forward with Bruce Power’s role in the LTEP, the supply of both Cobalt-60 and electricity could be secured for the long-term. Bruce Power provides nearly a third of Ontario’s electricity from its 8-unit facility in Southwestern Ontario at a cost of 30 per cent below the average cost of electricity in the province. Ontario’s LTEP has earmarked 6,300 MW of output from the Bruce Power site to meet the supply needs of Ontario for decades to come that will be enabled through a multi-year investment program to renew the site.
“Ontario has developed a nuclear power industry with an international reputation for safety, innovation and excellence - and an impressive history of supporting jobs at home,” said Hon. Bob Chiarelli, Ontario’s Minister of Energy and MPP (Ottawa West-Nepean). “Today’s announcement underscores the important contribution nuclear technology makes in our province.”
For more information about Cobalt-60, and Nordion’s partnership with Bruce Power, visit www.cleannuclearpowersafehospitals.com .
About Bruce Power
Bruce Power operates the world's largest
operating nuclear generating facility and is the source of roughly 30
per cent of Ontario's electricity. The company's site in Tiverton,
Ontario is home to eight CANDU reactors, each one capable of generating
enough low-cost, reliable, safe and clean electricity to meet the annual
needs of a city the size of Hamilton. Formed in 2001, Bruce Power is an
all-Canadian partnership among Borealis Infrastructure Management (a
division of the Ontario Municipal Employees Retirement System),
TransCanada, the Power Workers' Union and the Society of Energy
Professionals. A majority of Bruce Power's employees are also owners in
the business.
About Nordion
Nordion Inc. provides market-leading products
used for the prevention, diagnosis and treatment of disease. We are a
leading provider of medical isotopes and gamma technologies that benefit
the lives of millions of people around the world. Our products are used
daily by pharmaceutical and biotechnology companies, medical-device
manufacturers, hospitals, clinics and research laboratories. Nordion
supplies products to approximately 500 customers across more than 40
countries around the globe. Our parent company, Sterigenics
International LLC, is the global leader in contract sterilization and
ionization services for the medical devices, food safety and high
performance/specialty materials industries serving customers around the
world. Find out more at www.nordion.com
and follow us at twitter.com/NordionInc
.
Contact:
Nordion
Shelley Maclean, 613-592-3400 x2414
shelley.maclean@nordion.com
or
Bruce
Power
John Peevers, 519-361-6583
john.peevers@brucepower.com
Link:
Information om Business Wire
Følg pressemeddelelser fra Business Wire
Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.
Flere pressemeddelelser fra Business Wire
Bloom Announces Early 2026 UK Launch, Expanding into Europe with New Garden Pharma as Exclusive Manufacturer24.6.2025 07:05:00 CEST | Press release
The Bloom Brand, a recognized U.S. leader in cannabis vape, is making its international debut in the United Kingdom through an exclusive partnership with New Garden Pharma, a leading European EU-GMP cannabis operator. Together, the two companies will launch Bloom’s award-winning Classic and Live vape collections in the UK in Q1 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250623573625/en/ This marks Bloom’s first international market expansion, as the company continues its global growth strategy with additional EU markets in development for 2026 and beyond. UK patients will gain access to Bloom’s superior formulations and proprietary hardware systems. For more than a decade, Bloom has built its reputation on delivering terpene-rich, flavor-forward strains paired with reliable technology. The brand has an established and leading presence across leading U.S. markets including California, Illinois, Florida, Michigan, Mi
ACI Worldwide Expands Technology Partnership Ecosystem to Power ACI Connetic24.6.2025 07:00:00 CEST | Press release
ACI’s unified cloud-based payments platform to boost operational resiliency and support increasing non-functional requirements of modern payment systems ACI Worldwide (NASDAQ:ACIW), an original innovator in global payments technology, has expanded its global technology partnership ecosystem to help financial institutions across the globe increase operational resiliency and address evolving regulatory requirements to safeguard the stability of the financial system. Building on strategic partnerships with Microsoft, Red Hat and IBM, ACI is collaborating with MongoDB, a document-oriented NoSQL database, and open source technology NATS from Synadia Communications for the reference architecture of ACI Connetic, ACI’s unified, cloud-native payments platform. These partnerships help extend ACI Connetic far beyond a traditional payments hub, delivering robust, highly functional payment engines to support financial institutions in meeting growingly stringent non-functional requirements and incr
Industrial 3-axis accelerometer has high offset stability24.6.2025 04:00:00 CEST | Press release
Murata Manufacturing Co., Ltd. (TOKYO: 6981) (ISIN: JP3914400001) has introduced a 3-axis accelerometer for the industrial market that combines high offset stability over temperature and time, good linearity, low noise density, and excellent robustness. The SCA3400-D01 XYZ accelerometer is meant for use in industrial applications such as structural health monitoring (SHM), machine control, inertial measurement units, and construction tools and systems. This product will be exhibited at Sensors Converge 2025 to be held at the Santa Clara Convention Center (Booth #716), California from 24 to 26 June 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250623994075/en/ [Murata Manufacturing Co., Ltd.] Industrial 3-axis accelerometer The offset stability of an accelerometer refers to the consistency of its output when at rest, but subject to varying temperatures or the effects of aging. Ideally, this output should be zero, but i
Grid Dynamics Announces AI-Powered Engagement Model Enabling Accelerated Business Transformation for Fortune 1000 Enterprises23.6.2025 15:15:00 CEST | Press release
Key Takeaways: Grid Dynamics introduces an AI-powered engagement model for software delivery. This engagement model expands Grid Dynamics’ offerings by providing a fundamentally new way of delivering value—enabling clients to achieve superior outcomes by providing the next level of agility, quality, and accelerated time-to-market. The model is based on the Grid Dynamics AI-Native Development Framework (GAIN Development Framework)—a combination of proprietary processes, human capital, and an AI-Enabled Development Platform. This framework is designed specifically to support the scale and complexity of Fortune 1000 enterprises. Based on internal benchmarks, we expect this model to accelerate project delivery by achieving over 30% productivity improvements. Progressive credit-based pricing directly tied to performance and value is the basis of the new engagement model. Grid Dynamics Holdings, Inc. (Nasdaq: GDYN) (Grid Dynamics)—a prominent technology consulting and digital services provid
Live Biotherapeutics at a Crossroad: Novotech White Paper Outlines Opportunities and Early-Stage Challenges23.6.2025 14:05:00 CEST | Press release
As Live Biotherapeutic Products (LBPs) begin to transition from frontier science to clinical reality, Novotech, a leading global CRO and scientific advisory partner has published a new white paper examining the opportunities and challenges shaping this fast-evolving landscape of therapeutic class. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250623205345/en/ LBPs, which harness live microorganisms to restore or modulate human health, are being explored across a growing range of indications, from gastrointestinal and metabolic disorders to CNS and oncology. FDA approvals of Rebyota™ and Vowst™ have validated the category but for most biotech sponsors, the journey remains uncertain. According to Novotech’s analysis, over 90% of LBP assets are still in early development stages, and nearly one-third of all trials from 2020 to 2025 have been withdrawn or suspended due to regulatory, manufacturing, or design complexities. Highli
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.
Besøg vores nyhedsrum